Overview

Dupilumab in Severe Chronic Hand Eczema

Status:
Recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the efficacy of dupilumab in hand eczema patients with an inadequate response or intolerance to alitretinoin.

Phase:

Phase 2

Details

Lead Sponsor:

University Medical Center Groningen

Collaborator:

Sanofi Genzyme